help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, D. F.
Right arrow Articles by Kilpatrick, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, D. F.
Right arrow Articles by Kilpatrick, D. L.

Endocrinology, Vol 122, 1466-1471, Copyright © 1988 by Endocrine Society


ARTICLES

Estrous cycle- and pregnancy-related differences in expression of the proenkephalin and proopiomelanocortin genes in the ovary and uterus

DF Jin, KE Muffly, WC Okulicz and DL Kilpatrick
Neurobiology Group Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts 01545.

Expression of the genes for two opioid peptide precursors, proenkephalin and POMC, was examined within the female reproductive system of rodents as a function of the estrous cycle and during pregnancy. Proenkephalin RNA was found to change markedly during the estrous cycle in both the ovary and uterus (approximately 6- and 3- fold, respectively). The highest concentrations occurred at estrus in the rat ovary and at metestrus and diestrus in the rat uterus. In sharp contrast to proenkephalin RNA, the abundance of POMC RNA remained relatively constant throughout the estrous cycle in both tissues. Similar results were obtained in the cycling hamster ovary. During pregnancy, the concentrations of proenkephalin RNA in the rat ovary showed little variation, while in the uterus a 4-fold increase in this transcript was observed. The effects of pregnancy on POMC RNA were the reverse of this pattern; its abundance increased 2-fold in the ovary and did not vary substantially in the uterus. These differences in the expression of proenkephalin and POMC genes during the estrous cycle and pregnancy suggest that these two opioid peptide precursors are associated with distinct functional roles within the female reproductive system.


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
S Bauersachs, S E Ulbrich, K Gross, S E M Schmidt, H H D Meyer, R Einspanier, H Wenigerkind, M Vermehren, H Blum, F Sinowatz, et al.
Gene expression profiling of bovine endometrium during the oestrous cycle: detection of molecular pathways involved in functional changes
J. Mol. Endocrinol., June 1, 2005; 34(3): 889 - 908.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
J.L. Kornyei, Z. Vertes, A. Oszter, K.A. Kovacs, Ch.V. Rao, and M. Vertes
Opioid peptides inhibit the action of oestradiol on human myometrial cells in culture
Mol. Hum. Reprod., June 1, 1999; 5(6): 565 - 572.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Zhu and J. E. Pintar
Expression of Opioid Receptors and Ligands in Pregnant Mouse Uterus and Placenta
Biol Reprod, October 1, 1998; 59(4): 925 - 932.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society